Many chronic heart failure patients struggle with not just strenuous activity but even the essentials such as moderate exercise and normal breathing. Research revealed at the Society of Nuclear Medicine's 2012 Annual Meeting ...
Jun 11, 2012
Patients with cardiovascular disease will now benefit from a powerful new molecular imaging tool to detect disease in the main arteries supplying oxygen to the heart, say researchers presenting studies at the Society of Nuclear ...
Jun 11, 2012
Finding a way to restore hair growth after substantial hair loss is something of an obsession worldwide. Investigators at the Society of Nuclear Medicine's 2012 Annual Meeting presented how stem cell research for the development ...
Jun 11, 2012
(HealthDay) -- Perjeta (pertuzumab) has been approved by the U.S. Food and Drug Administration to treat people with HER2-positive late-stage breast cancer, the agency said in a news release.
Jun 11, 2012
Research presented at the Society of Nuclear Medicine's 59th Annual Meeting reveals that patients with differentiated thyroid cancer live as long as people in perfect health, unless they are in the minority and have reached ...
Jun 11, 2012
A development in 4D image reconstruction compensates for blurring caused by the beating of the heart, say researchers at the Society of Nuclear Medicine's 59th Annual Meeting. The new method provides sharper-than-ever images ...
Jun 11, 2012
Out of control competitive aggression could be a result of a lagging neurotransmitter called dopamine, say researchers presenting a study at the Society of Nuclear Medicine's 2012 Annual Meeting. During a computer game against ...
Jun 11, 2012
A study revealed at the Society of Nuclear Medicine's 59th Annual Meeting provides some hope for those with a malignant brain cancer called glioma.A method of molecular imaging that mimics an essential amino acid in the brain ...
Jun 11, 2012
Research revealed at the Society of Nuclear Medicine's 2012 Annual Meeting explores treatment with a newly developed type of radioimmunotherapy used for treating a resistant form of kidney cancer. The agent is able to hone ...
Jun 11, 2012
Research revealed at the Society of Nuclear Medicine's 2012 Annual Meeting describes new approaches to imaging for the detection of tumors in complex cases of bone cancer. Hybrid imaging technology combining computed tomography ...
Jun 11, 2012
